HUMAN CYTOMEGALOVIRUS GB POLYPEPTIDE
    3.
    发明申请

    公开(公告)号:US20190127422A1

    公开(公告)日:2019-05-02

    申请号:US16082177

    申请日:2017-03-09

    Applicant: Pfizer Inc.

    Abstract: The present invention relates to a polypeptide that includes at least one mutation in the fusion loop 1 region and/or in the fusion loop 2 region and/or in the furin-like cleavage site of a human cytomegalovirus gB polypeptide. In one embodiment, the polypeptide undergoes a structural conformation change in response to pH change.

Patent Agency Ranking